GSK Looks For New Chair To Lead It Through New Strategic Direction
Executive Summary
GSK’s non-exec chairman steps down from the UK firm, just a month after announcing a split that will reshape the company.
You may also be interested in...
Pfizer Consumer Combo Deal Frees Capital For GSK Pharma Investment
Separating out its consumer business in a joint venture with Pfizer will open up investment possibilities for GlaxoSmithKline's pharma and vaccine businesses.
New CFO Mackay Completes Top Table At GSK
CEO Emma Walmsley’s plans to transform the leadership at GSK have advanced again with the appointment of HSBC's Iain Mackay as the firm's new chief financial officer.
Investment And Acquisition In Rare Diseases
In Vivo talks to investors, analysts and companies in rare disease about the challenges they face to innovate and to grow.